Clinical Trials Arena Team, Author at Clinical Trials Arena https://www.clinicaltrialsarena.com/author/clinicaltrialsarena/ Hard data and deep insights on clinical trials strategy & operations Mon, 30 Sep 2024 09:11:32 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/cropped-Clinical-Trials-Arena-32x32.png Clinical Trials Arena Team, Author at Clinical Trials Arena https://www.clinicaltrialsarena.com/author/clinicaltrialsarena/ 32 32 Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial https://www.clinicaltrialsarena.com/features/pipeline-moves-pfizer-scores-in-phase-ii-cancer-cachexia-trial/ Mon, 30 Sep 2024 09:00:00 +0000 This week on Pipeline Moves, the Clinical Trials Arena team investigates candidates in oncology, central nervous system and women’s health.

The post Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial appeared first on Clinical Trials Arena.

]]>
Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial https://www.clinicaltrialsarena.com/features/novo-nordisk-saxenda-scores-paediatric-trial/ Mon, 16 Sep 2024 15:59:02 +0000 https://www.clinicaltrialsarena.com/features/novo-nordisk-saxenda-scores-paediatric-trial/ The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

The post Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial appeared first on Clinical Trials Arena.

]]>
Pipeline Moves: Investigator-led oncology cell therapy trial terminated https://www.clinicaltrialsarena.com/features/oncology-cell-therapy-termination-investigator/ Mon, 02 Sep 2024 09:39:30 +0000 https://www.clinicaltrialsarena.com/features/oncology-cell-therapy-termination-investigator/ The Clinical Trials Arena team investigates assets in oncology, genetic disorders, autoimmune diseases and respiratory diseases.

The post Pipeline Moves: Investigator-led oncology cell therapy trial terminated appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Investigator-led oncology cell therapy trial terminated appeared first on Clinical Trials Arena.

]]>
Pipeline Moves: Moderna’s pandemic influenza vaccine trial completes https://www.clinicaltrialsarena.com/features/pipeline-moves-moderna-pandemic-trial-vaccine-completes/ Mon, 19 Aug 2024 09:29:33 +0000 https://www.clinicaltrialsarena.com/features/pipeline-moves-moderna-pandemic-trial-vaccine-completes/ The Clinical Trials Arena team investigates assets in oncology, central nervous system and infectious diseases.

The post Pipeline Moves: Moderna’s pandemic influenza vaccine trial completes appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Moderna’s pandemic influenza vaccine trial completes appeared first on Clinical Trials Arena.

]]>
Pipeline Moves: Novartis terminates Phase II ALS trial after benefit-risk worry https://www.clinicaltrialsarena.com/features/pipeline-moves-novartis-terminate-phase-ii-als-trial-after-benefit-risk-worry/ Tue, 06 Aug 2024 08:22:24 +0000 https://www.clinicaltrialsarena.com/features/pipeline-moves-novartis-terminate-phase-ii-als-trial-after-benefit-risk-worry/ On this week's Pipeline Moves, the Clinical Trials Arena team investigates assets in the central nervous system, oncology and immunology.

The post Pipeline Moves: Novartis terminates Phase II ALS trial after benefit-risk worry appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Novartis terminates Phase II ALS trial after benefit-risk worry appeared first on Clinical Trials Arena.

]]>
Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated https://www.clinicaltrialsarena.com/features/novo-nordisk-progression-drop-drug-termination/ Mon, 22 Jul 2024 08:00:00 +0000 This week on Pipeline Moves, the Clinical Trials Arena team investigates candidates in genetic disorders, oncology and infectious diseases.

The post Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated appeared first on Clinical Trials Arena.

]]>
Pipeline Moves: Alnylam’s Amvuttra approval prospects up after Phase III win https://www.clinicaltrialsarena.com/features/alnylam-win-amvuttra-attr-amyloidosis/ Mon, 08 Jul 2024 08:36:04 +0000 https://www.clinicaltrialsarena.com/features/alnylam-win-amvuttra-attr-amyloidosis/ The Clinical Trials Arena team also investigates candidates in metabolic disorders, oncology and central nervous system.

The post Pipeline Moves: Alnylam’s Amvuttra approval prospects up after Phase III win appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Alnylam’s Amvuttra approval prospects up after Phase III win appeared first on Clinical Trials Arena.

]]>
Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion https://www.clinicaltrialsarena.com/features/pipeline-moves-approval-prospects-diabetic-foot-ulcer-biotissue/ Mon, 24 Jun 2024 08:03:00 +0000 https://www.clinicaltrialsarena.com/features/pipeline-moves-approval-prospects-diabetic-foot-ulcer-biotissue/ The Clinical Trials Arena team evaluates assets in cardiovascular, dermatology and oncology.

The post Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion appeared first on Clinical Trials Arena.

]]>
Pipeline Moves: Pfizer’s oral Nurtec approval prospects rise after Phase II/III completion https://www.clinicaltrialsarena.com/features/pipeline-moves-pfizer-prospects-rise-nurtec-completion/ Mon, 10 Jun 2024 09:10:31 +0000 https://www.clinicaltrialsarena.com/uncategorized/pipeline-moves-pfizer-prospects-rise-nurtec-completion/ The Clinical Trials Arena team evaluates assets in oncology and cardiovascular and ear, nose and throat disorders.

The post Pipeline Moves: Pfizer’s oral Nurtec approval prospects rise after Phase II/III completion appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Pfizer’s oral Nurtec approval prospects rise after Phase II/III completion appeared first on Clinical Trials Arena.

]]>
Pipeline Moves: Phase III AML trial fails to meet primary endpoint https://www.clinicaltrialsarena.com/features/pipeline-moves-aml-trial-fails-endpoints/ Tue, 28 May 2024 08:00:00 +0000 The Clinical Trials Arena team evaluates assets in oncology and gastrointestinal disorders.

The post Pipeline Moves: Phase III AML trial fails to meet primary endpoint appeared first on Clinical Trials Arena.

]]>
The post Pipeline Moves: Phase III AML trial fails to meet primary endpoint appeared first on Clinical Trials Arena.

]]>